Association of serum paraoxonase concentration with serum lipid levels and bone mineral density measurements in early postmenopausal women

References

• Parhami F, Garfinkel A, Demer LL. Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 2000;20:2346–8
   PubMed Web of Science ®Google Scholar
• Adami S, Braga V, Zamboni M, et al. Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int 2004;74:136–42
   PubMed Web of Science ®Google Scholar
• Brownbill RA, Ilich JZ. Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women. J Womens Health 2006;15:261–70
   PubMed Web of Science ®Google Scholar
• Samelson EJ, Cupples LA, Hannan MT, et al. Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham Osteoporosis Study. Bone 2004;34:557–61
   PubMed Web of Science ®Google Scholar
• Parhami F, Morrow AD, Balucan J, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 1997;17:680–7
   PubMed Web of Science ®Google Scholar
• Almeida M, Ambrogini E, Han L, Manolagas SC, Jilka RL. Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. J Biol Chem 2009;284:27438–48
   PubMed Web of Science ®Google Scholar
• Parhami F, Jackson SM, Tintut Y, et al. Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 1999;14:2067–78
   PubMed Web of Science ®Google Scholar
• Tintut Y, Parhami F, Tsingotjidou A, Tetradis S, Territo M, Demer LL. 8-Isoprostaglandin E2 enhances receptoractivated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem 2002;277:14221–6
   PubMed Web of Science ®Google Scholar
• Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 1991;286:152–4
   PubMed Web of Science ®Google Scholar
• Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005;69: 541–50
   PubMed Web of Science ®Google Scholar
• Demer LL. Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int J Epidemiol 2002;31:737–41
   PubMed Web of Science ®Google Scholar
• Kim BJ, Kim SY, Cho YS, et al. Association of paraoxonase 1 (PON) polymorphisms with osteoporotic fracture risk in postmenopausal Korean women. Exp Mol Med 2011;43:71–81
   PubMed Web of Science ®Google Scholar
• Bagger YZ, Rasmussen HB, Alexandersen P, Werge T, Christiansen C, Tanko LB. Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se? Osteoporos Int 2006;18:505–12
   PubMed Web of Science ®Google Scholar
• Verit FF, Celik H, Yazgan P, Erel O, Geyikli I. Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women. Arch Gynecol Obstet 2006;275:353–9
   PubMedGoogle Scholar
• Balogh Z, Seres I, Marangi M, Kovacs P, Kakuk G, Paragh G. Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates? Diabetes Metab 2001;27:604–10
   PubMed Web of Science ®Google Scholar
• Paragh G, Seres I, Harangi M, et al. The effects of micronized fenofibrate on paraoxonase activity in patients with coronary heart disease. Diabetes Metab 2003;29:613–18
   PubMed Web of Science ®Google Scholar
• Turay J, Grniakova V, Valka J. Changes in paraoxonase and apolipoprotein A-I, B, B-III and E in subjects with combined familiar hyperlipoproteinemia treated with ciprofibrate. Drugs Exp Clin Res 2000;26:83–8
   PubMedGoogle Scholar
• Durrington PN, Mackness MI, Bhatnagar D, et al. Effects of two different fibric acid derivatives on lipoproteins, cholesterol ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinemia. Atherosclerosis 1998;138:217–25
   PubMed Web of Science ®Google Scholar
• Blatter-Garin MC, Kalix B, De Pre S, James RW. Aspirin use is associated with higher serum concentrations of the antioxidant enzyme, paraoxonase-1. Diabetologia 2003;46:593–4
   PubMed Web of Science ®Google Scholar
• James RW, Leviev I, Righetti A. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. Circulation 2000;101:2252–7
   PubMed Web of Science ®Google Scholar
• Senti M, Tomas M, Anglada R, et al. Inter-relationship of smoking, paraoxonase activity, and leisure time physical activity: a population-based study. Eur J Int Med 2003;14:178–84
   PubMedGoogle Scholar
• van der Gaag MS, van Tol A, Scheek LM, et al. Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomized intervention study in middle-aged men. Atherosclerosis 1999;147:405–10
   PubMed Web of Science ®Google Scholar
• Sierksma A, van der Gaag MS, van Tol A, James RW, Hendriks HFJ. Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers. Alcohol Clin Exp Res 2002;26:1430–5
   PubMed Web of Science ®Google Scholar
• Rao MN, Marmillot P, Gong M, et al. Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans. Metabolism 2003;52:1287–94
   PubMed Web of Science ®Google Scholar
• Sutherland WHF, Walker RJ, de Jong SA, van Rij AM, Phillips V, Walker HL. Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat. Arterioscler Thromb Vasc Biol 1999;19:1340–7
   PubMed Web of Science ®Google Scholar
• de Roos NM, Schouten EG, Scheek LM, van Tol A, Katan MB. Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women. Metabolism 2002;51:1534–7
   PubMed Web of Science ®Google Scholar
• Wallace AJ, Sutherland WHF, Mann JI, Williams SM. The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes. Eur J Clin Nutr 2001;55:951–8
   PubMed Web of Science ®Google Scholar
• Ferré N, Camps J, Fernandez-Ballart J, et al. Regulation of serum paraoxonase activity by genetic, nutritional and lifestyle factors in the general population. Clin Chem 2003;49:1491–7
   PubMed Web of Science ®Google Scholar
• Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 2001;288:275–9
   PubMed Web of Science ®Google Scholar
• Hall SL, Greendale GA. The relation of dietary vitamin C intake to bone mineral density: results from the PEPI study. Calcif Tissue Int 1998;63:183–9
   PubMed Web of Science ®Google Scholar
• Maggio D, Barabani M, Pierandrei M, et al. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 2003;88: 1523–7
   PubMed Web of Science ®Google Scholar
• Wang MC, Luz Villa M, Marcus R, Kelsey JL. Associations of vitamin C, calcium, and protein with bone mass in postmenopausal Mexican American women. Osteoporos Int 1997; 7:533–8
   PubMed Web of Science ®Google Scholar
• Arlot ME, Sornay-Rendu E, Garnero P, Vey-Marty B, Delmas PD. Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort. J Bone Miner Res 1997;12:683–90
   PubMed Web of Science ®Google Scholar
• Duan Y, Parfitt A, Seeman E. Vertebral bone mass, size, and volumetric density in women with spinal fractures. J Bone Miner Res 1999;14:1796–9
   PubMed Web of Science ®Google Scholar
• Thomsen AB, Silvestri S, Haarbo J, Christiansen C, Bjarnason NH. Associated response in bone and lipids during hormone replacement therapy. Maturitas 2004;47:39–45
   PubMed Web of Science ®Google Scholar
• Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 2001;16:182–8
   PubMed Web of Science ®Google Scholar
• Tanko LB, Bagger YZ, Nielsen SB, Christiansen C. Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? Bone 2003;32:8–14
   PubMed Web of Science ®Google Scholar
• Samelson EJ, Cupples LA, Hannan MT, et al. Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham Osteoporosis Study. Bone 2004;34: 557–61
   PubMed Web of Science ®Google Scholar
• Vogt MT, Cauley JA, Kuller LH, Nevitt MC. Bone mineral density and blood flow to the lower extremities: the Study of Osteoporotic Fractures. J Bone Miner Res 1997;12:283–9
   PubMed Web of Science ®Google Scholar
• Tanko LB, Bagger YZ, Christiansen C. Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int 2003;73:15–20
   PubMed Web of Science ®Google Scholar
• Yamada Y, Ando F, Niino N, Miki T, Shimokata H. Association of polymorphisms of paraoxonase 1 and 2 genes, alone or in combination, with bone mineral density in community-dwelling Japanese. J Hum Genet 2003;48:469–75
   PubMed Web of Science ®Google Scholar